Annual Cash & Cash Equivalents
$149.50 K
-$2.12 M-93.43%
September 30, 2024
Summary
- As of February 26, 2025, SONN annual cash & cash equivalents is $149.50 thousand, with the most recent change of -$2.12 million (-93.43%) on September 30, 2024.
- During the last 3 years, SONN annual cash & cash equivalents has fallen by -$27.47 million (-99.46%).
- SONN annual cash & cash equivalents is now -99.46% below its all-time high of $27.62 million, reached on September 30, 2021.
Performance
SONN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.86 M
+$4.71 M+3151.84%
December 31, 2024
Summary
- As of February 26, 2025, SONN quarterly cash and cash equivalents is $4.86 million, with the most recent change of +$4.71 million (+3151.84%) on December 31, 2024.
- Over the past year, SONN quarterly cash and cash equivalents has stayed the same.
- SONN quarterly cash and cash equivalents is now -82.40% below its all-time high of $27.62 million, reached on September 30, 2021.
Performance
SONN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SONN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.4% | 0.0% |
| 3 y3 years | -99.5% | -57.3% |
| 5 y5 years | +318.8% | -57.3% |
SONN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | at low | -75.0% | +3151.8% |
| 5 y | 5-year | -99.5% | +318.8% | -82.4% | +3151.8% |
| alltime | all time | -99.5% | +318.8% | -82.4% | +3151.8% |
Sonnet BioTherapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $4.86 M(+3151.8%) |
| Sep 2024 | $149.50 K(-93.4%) | $149.50 K(-95.8%) |
| Jun 2024 | - | $3.55 M(-6.1%) |
| Mar 2024 | - | $3.79 M(+25.3%) |
| Dec 2023 | - | $3.02 M(+32.8%) |
| Sep 2023 | $2.27 M(-25.5%) | $2.27 M(-67.6%) |
| Jun 2023 | - | $7.02 M(-38.4%) |
| Mar 2023 | - | $11.39 M(+569.8%) |
| Dec 2022 | - | $1.70 M(-44.3%) |
| Sep 2022 | $3.05 M | $3.05 M(-41.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $5.22 M(-61.7%) |
| Mar 2022 | - | $13.64 M(-29.7%) |
| Dec 2021 | - | $19.41 M(-29.7%) |
| Sep 2021 | $27.62 M(+275.8%) | $27.62 M(+357.5%) |
| Jun 2021 | - | $6.04 M(-10.4%) |
| Mar 2021 | - | $6.74 M(+187.0%) |
| Dec 2020 | - | $2.35 M(-68.1%) |
| Sep 2020 | $7.35 M(>+9900.0%) | $7.35 M(+136.6%) |
| Jun 2020 | - | $3.11 M(+466.0%) |
| Mar 2020 | - | $548.90 K |
| Sep 2019 | $35.70 K | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is Sonnet BioTherapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of SONN is $149.50 K
What is the all time high annual cash & cash equivalents for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual cash & cash equivalents is $27.62 M
What is Sonnet BioTherapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, SONN annual cash & cash equivalents has changed by -$2.12 M (-93.43%)
What is Sonnet BioTherapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SONN is $4.86 M
What is the all time high quarterly cash and cash equivalents for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly cash and cash equivalents is $27.62 M
What is Sonnet BioTherapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, SONN quarterly cash and cash equivalents has changed by $0.00 (0.00%)